Conjunctivitis in patients with atopic dermatitis treated with dupilumab

Atopic dermatitis (AD) is a common, chronic, inflammatory skin disorder with high physical and emotional burden. Robust evidence suggests that interleukin (IL)-4 and IL-13 are key cytokines in the immunopathogenesis of AD. New emerging agents include dupilumab, a fully human monoclonal antibody dire...

Full description

Bibliographic Details
Main Author: Ferreira, Sandra (author)
Other Authors: Torres, Tiago (author)
Format: article
Language:eng
Published: 2021
Subjects:
atopic dermatitis
atopic eczema
conjunctivitis
dupilumab
Online Access:http://hdl.handle.net/10400.16/2585
Country:Portugal
Oai:oai:repositorio.chporto.pt:10400.16/2585

Internet

http://hdl.handle.net/10400.16/2585

Similar Items